13:06 IST
BSE
Annual General Meeting
Skybiotech Healthcare Annual General Meeting
Skybiotech Healthcare Ltd has issued the notice for its 43rd Annual General Meeting. The meeting is scheduled to be held on September 30, 2026.
Skybiotech Healthcare Ltd
- Share price
- ₹114.00
- Market cap
- ₹21.83 Cr
- Revenue (annual)
- ₹7.10 Cr
- Net profit (annual)
- ₹-1.12 Cr
- P/E (TTM)
- -13.1×Sector 55.7×
- Promoter holding
- 63.48%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
4 announcements
12:37 IST
BSE
Annual Report
Skybiotech Healthcare Annual Report
Skybiotech Healthcare Ltd has filed its Annual Report for the financial year 2025-26, pursuant to Regulation 34 of the SEBI LODR Regulations.
20:59 IST
BSE
Financial Results
Skybiotech Healthcare Q1 FY27 Results: Net Loss of ₹0.6 Cr
Skybiotech Healthcare Ltd reported revenue from operations of ₹0.5 Cr (-79.2% YoY) and a net loss of ₹0.6 Cr for Q1 FY27.
- Key figure
- Net loss ₹0.6 Cr
19:44 IST
BSE
Financial Results
Skybiotech Healthcare Q4 FY26 Results: Net Loss of ₹0.3 Cr, Loss Narrows
Skybiotech Healthcare Ltd reported revenue from operations of ₹1.8 Cr (+80.0% YoY) and a net loss of ₹0.3 Cr for Q4 FY26.
- Key figure
- Net loss ₹0.3 Cr